Effects of obesity and weight loss on the expression of proteins involved in fatty acid metabolism in human adipose tissue

International Journal of Obesity

Volumn 26, Issue 10, 2002, Pages 1379-1385

  Fisher, R M ^a   Hoffstedt, J ^a   Hotamisligil, G S ^b   Thorne A ^a   Ryden M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adipocyte lipid binding protein; Adipose tissue; Fatty acid translocase; Keratinocyte lipid binding protein; Obesity

Indexed keywords

FATTY ACID; LIPID BINDING PROTEIN;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; FATTY ACID METABOLISM; FEMALE; HORMONAL REGULATION; HUMAN; INSULIN RESISTANCE; KERATINOCYTE; LIPID BLOOD LEVEL; LIPOLYSIS; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLUBILIZATION; TISSUE SPECIFICITY; WEIGHT REDUCTION; WESTERN BLOTTING;

ACTINS; ADIPOSE TISSUE; ADULT; ANTIGENS, CD36; BLOTTING, WESTERN; CARRIER PROTEINS; CASE-CONTROL STUDIES; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; OBESITY; ORGANIC ANION TRANSPORTERS; TUMOR SUPPRESSOR PROTEINS; WEIGHT LOSS;

EID: 0036797764     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802110     Document Type: Article

References (28)

1. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997; 46: 3-10.
2. Silverstein RL, Febbraio M. CD36 and atherosclerosis. Curr Opin Lipidol 2000; 11: 483-491.
3. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, Al-Majali KM, Trembling PM, Mann CJ, Shoulders CC, Graf D, St Lezin E, Kurtz TW, Kren V, Pravenec M, Ibrahimi A, Abumrad N, Stanton LW, Scott J. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nature Genet 1999; 21: 76-83.
4. Tanaka T, Nakata T, Oka T, Ogawa T, Okamoto F, Kusaka Y, Sohmiya K, Shimamoto T, Itakura K. Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations. J Lipid Res 2001; 42: 751-759.
5. Febbraio M, Abumrad NA, Hajjar DP, Sharman K, Cheng W, Pearce SFA, Silverstein RL. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 1999; 274: 19055-19062.
6. Coburn CT, Knapp FFJr, Febbraio M, Beets AL, Silverstein RL, Abumrad NA. Defective uptake and utilization of long-chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem 2000; 275: 32523-32529.
7. Ibrahimi A, Bonen A, Blinn WD, Hajri T, Li X, Zhong K, Cameron R, Abumrad NA. Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J Biol Chem 1999; 274: 26761-26766.
8. Ribarik Coe N, Bernlohr DA. Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim Biophys Acta 1998; 1391: 287-306.
9. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 1996; 274: 1377-1379.
10. Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS. Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 2000; 141: 3388-3396.
11. Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, Parker RA, Suttles J, Fazio S, Hotamisligil GS, Linton MF. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nature Med 2001; 7: 699-705.
12. Ribarik Coe N, Simpson MA, Bernlohr DA. Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. J Lipid Res 1999; 40: 967-972.
13. −/− mice. Diabetes 1999; 48: 1987-1994.
14. Helledie T, Antonius M, Sorensen RV, Hertzel AV, Bernlohr DA, Kølvraa S, Kristiansen K, Mandrup S. Lipid-binding proteins modulate ligand-dependent trans-activation by peroxisome proliferator-activated receptors and localize to the nucleus as well as the cytoplasm. J Lipid Res 2000; 41: 1740-1751.
15. Arner P. Hunting for human obesity genes? Look in the adipose tissue! Int J Obes Relat Metab Disord 2000; 24(Suppl 4): S57-S62.
16. Large V, Reynisdottir S, Eleborg L, van Harmelen V, Strömmer L, Arner P. Lipolysis in human fat cells obtained under local and general anesthesia. Int J Obes Relat Metab Disord 1997; 21: 78-82.
17. Arner P. Techniques for the measurement of white adipose tissue metabolism: A practical guide. Int J Obes Relat Metab Disord 1995; 7: 435-442.
18. Fisher RM, Eriksson P, Hoffstedt J, Hotamisligil G, Thörne A, Rydén M, Hamsten A, Arner P. Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals. Diabetologia 2001; 44: 1268-1273.
19. Elizalde M, Rydén M, van Harmelen V, Eneroth P, Gyllenhammar H, Holm C, Ramel S, Olund A, Arner P, Andersso K. Expression of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans. J Lipid Res 2000; 41: 1244-1251.
20. Schmittgen TD, Zakrajsek BA. Effect of experimental treatment on housekeeping gene expression: Validation by real-time, quantitative RT-PCR. J Biochem Biophys Meth 2000; 46: 69-81.
21. van Harmelen V, Lönnqvist F, Thörne A, Wennlund A, Large V, Arner P. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects. Int J Obes Relat Metab Disord 1997; 21: 972-979.
22. Shen W-J, Liang Y, Patel S, Natu V, Sridhar K, Jenkins A, Bernlohr DA, Kraemer FB. Characterization of the functional interaction of adipocyte lipid-binding protein with hormone-sensitive lipase. J Biol Chem 2001; 276: 49443-49448.
23. Arner P. Regulation of lipolysis in fat cells. Diabetes Rev 1996; 4: 450-463.
24. Luiken JJFP, Arumugam Y, Dyck DJ, Bell RC, Pelsers MML, Turcotte LP, Tandon NN, Glatz JFC, Bonen A. Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese zucker rats. J Biol Chem 2001; 276: 40567-40573.
25. Arner F, Lithell H, Wahrenberg H, Bronnegard M. Expression of lipoprotein lipase in different human subcutaneous adipose tissue regions. J Lipid Res 1991; 32: 423-429.
26. Kolehmainen M, Vidal H, Ohisalo JJ, Pirinen E, Alhava E, Uusitupa MI. Hormone sensitive lipase expression and adipose tissue metabolism show gender difference in obese subjects after weight loss. Int J Obes Relat Metab Disord 2002; 26: 6-16.
27. Löfgren P, Hoffstedt J, Rydén M, Thörne A, Holm C, Wahrenberg H, Arner P. Major gender differences in the lipolytic capacity of abdominal subcutaneous fat cells in obesity observed before and after long-term weight reduction. J Clin Endocrinol Metab 2002; 87: 764-771.
28. Frayn KN, Williams CM, Arner P. Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases? Clin Sci 1996; 90: 243-253.